Novosti iz različitih područja znanosti

Sara ReardonThursday 23 November 2017

AI-controlled brain implants for mood disorders tested in people

Nature:  Brain implants that deliver electrical pulses tuned to a person’s feelings and behaviour are being tested in people for the first time. Two teams funded by the US military’s research arm, the Defense Advanced Research Projects Agency (DARPA), have begun preliminary trials of ‘closed-loop’ brain implants that use algorithms to detect patterns associated with mood disorders. These devices can shock the brain back to a healthy state without input from a physician.

Greg Von Portz Tuesday 21 November 2017

A Visual Guide to the New Blood Pressure Guidelines

MedPage Today: The American College of Cardiology and American Heart Association's new blood pressure guidelines came in a comprehensive, and thus ponderous, 192-page document.

      130/80 mm Hg is the new 140/90 mm Hg, but there’s more to the new guideline with two stages of hypertension and a new name for prehypertension. 


The New York TimesSaturday 18 November 2017

Yes, you are being watched

The US Food and Drug Administration has approved an antipsychotic pill embedded with a sensor that tracks when a person swallows it. But some question the whether a drug used to treat schizophrenia is well-suited to an innovation that monitors behaviour and sends signals to doctors. “There’s an irony in it being given to people with mental disorders that can include delusions. It’s like a biomedical Big Brother,” says psychiatrist Jeffrey Lieberman.

 

The New York Times


NatureSaturday 18 November 2017

First-ever gene editing in a human body

A person with a metabolic disease called Hunter syndrome has received the first ever in vivo gene-editing therapy. If successful, the treatment will permanently change his DNA and cure the disease.

 

Read Nature’s primer on the new wave of gene-editing therapies (from 2015).


Milan TaradiTuesday 26 August 2008

Dobrodošli u novosti iz znanosti

Dobrodošli u u novosti iz znanosti. Test sustava. Svoj prilog možete poslati na mail  milan.taradi(et)gmail.com